Miczone T 500mg/62.5mg Injection
Marketer
Medifaith Biotech
Salt Composition
Ceftriaxone (500mg) + Tazobactum (62.5mg)
Overview Miczone T 500mg/62.5mg Injection
Combithal 500mg/62.5mg Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, thus containing infection spread. Administration must be solely under a doctor's guidance; strict adherence to the prescribed regimen is crucial, completing the full course even with symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical attention. Seek immediate help for allergic reactions (rash, pruritus, edema, dyspnea). Prior to use, disclose all current medications and pre-existing conditions. Expectant and nursing mothers require physician consultation. Alcohol should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and hydration are essential for optimal recovery. Your physician may order lab tests to monitor treatment response.
Primary Ingredients of Miczone T 500mg/62.5mg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Miczone T 500mg/62.5mg Injection
Infections caused by bacteria
Major Benefits of Miczone T 500mg/62.5mg Injection:
Administering this medication will be done by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Miczone T 500mg/62.5mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Miczone T 500mg/62.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Miczone T 500mg/62.5mg Injection works:
Ceftriaxone/Tazobactum injection (Miczone T 500mg/62.5mg) unites a cephalosporin antibiotic with a beta-lactamase inhibitor. Ceftriaxone's antibacterial action disrupts bacterial cell wall synthesis, crucial for bacterial viability. The addition of Tazobactum overcomes bacterial resistance mechanisms, bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Miczone T 500mg/62.5mg Injection may be used concurrently with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
Miczone T 500mg/62.5mg injection is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or absent negative consequences for fetal development; however, clinical data from human trials remain scarce.
Breast feedingCAUTION
The administration of Miczone T 500mg/62.5mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily suspended throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Miczone T 500mg/62.5mg Injection can induce drowsiness, blurred vision, and dizziness. Operating a vehicle is contraindicated if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Miczone T 500mg/62.5mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The 500mg/62.5mg Miczone T Injection requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage alteration for the 500mg/62.5mg Miczone T Injection is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Miczone T 500mg/62.5mg Injection :
Should you forget a scheduled dose of Miczone T 500mg/62.5mg Injection, seek advice from your physician.
Facts to Know About Miczone T 500mg/62.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently